Ledger.Open graph →
SEC Form D · filed September 21, 2016

Immune-Onc Therapeutics, Inc

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Xiaoling Charlene Liao · Palo Alto, CAExec · DirectorGuo-Liang Yu · Palo Alto, CADirectorLiqun Luo · Palo Alto, CADirectorXiaoling Charlene Liao · Palo Alto, CAExec · DirectorGuo-Liang Yu · Palo Alto, CADirectorLiqun Luo · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗